Efficacy of delayed or discontinuous FK506 administrations on nerve regeneration in the rat sciatic nerve crush model: Lack of evidence for a conditioning lesion-like effect

Neuroscience Letters

Volumn 267, Issue 1, 1999, Pages 33-36

  Gold, Bruce G ^a   Gordon, Heidi S ^a   Wang, M S ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Axonal caliber; Conditioning lesion; FK506; FKBP; Myelin sheath; Nerve regeneration; Sciatic nerve

Indexed keywords

TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRUSH TRAUMA; DOSE RESPONSE; DRUG EFFICACY; MYELINATION; NERVE REGENERATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SOLEUS MUSCLE; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; AXONS; INJECTIONS, SUBCUTANEOUS; MICROSCOPY, ELECTRON; NERVE CRUSH; NERVE FIBERS, MYELINATED; NERVE REGENERATION; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; TACROLIMUS; TIME FACTORS;

EID: 0033591398     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00333-X     Document Type: Article

References (20)

1. Czar M.J., Owens-Grillo J.K., Yem A.W., Leach K.L., Deibel M.R. Jr, Welsh M.J., Pratt W.B. The hsp56 immunophilin component of untransformed steroid receptor complexes is localized both to microtubules in the cytoplasm and to the same nonrandom regions within the nucleus as the steroid receptor. Mol. Endocrin. 8:1994;1731-1741.
2. Dumont F.J., Staruch M.J., Koprak S.L., Siekierka J.J., Lin C.S., Harrison R., Sewell T., Kindt V.M., Beattie T.R., Wyvratt M., Sigal N.H. The immunosuppressive and toxic effects of FK-506 are mechanistically related: Pharmacology of a novel antagonist of FK-506 and rapamycin. J. Exp. Med. 176:1992;751-760.
3. Freman D.A., Klee C.B., Bierer B.E., Burakoff S.J. Calcineurin phosphatase activity in T lymphocytes is inhibited by FK506 and cyclosporin A. Proc. Natl. Acad. Sci. USA. 89:1992;3686-3690.
4. Gold B.G., Densmore V., Shou W., Matzuk M.M., Gordon H.S. Immunophilin FK506-binding protein 52 (not FK506-binding protein 12) mediates the neurotrophic action of FK506. J. Pharmacol. Exp. Ther. 289:1999;1202-1210.
5. Gold B.G., Katoh K., Storm-Dickerson T. The immunosuppressant FK506 increases the rate of axonal regeneration in rat sciatic nerve. J. Neurosci. 15:1995;7509-7516.
6. Gold B.G., Storm-Dickerson T., Austin D.R. The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury. Restor. Neurol. Neurosci. 6:1994;287-296.
7. Gold B.G., Zeleny-Pooley M., Chaturvedi P., Wang M.S. Oral administration of a non-immunosuppressant FKBP-12 ligand speeds nerve regeneration. NeuroReport. 9:1998;553-558.
8. Gold B.G., Zeleny-Pooley M., Wang M.S., Chaturvedi P., Armistead D.M. A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration. Exp. Neurol. 147:1997;269-278.
9. Jacob J.M., McQuarrie I.G. Acceleration of axonal outgrowth in rat sciatic nerve at one week after axotomy. J. Neurobiol. 24:1993;356-367.
10. Lebeau M.C., Massol N., Herrick J., Faber L.E., Renoin M.J., Radanyi C., Baulieu E.E. P59, an hsp 90-binding protein. Cloning and sequencing of its cDNA and preparation of a peptide-directed polyclonal antibody. J. Biol. Chem. 267:1992;4281-4284.
11. Liu J., Farmer J.D., Lane W.S., Friedman J., Weissman I., Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 66:1991;807-815.
12. Owens-Grillo J.K., Hoffmann K., Hutchison K.A., Yem A.W., Deibel M.R. Jr, Handschumacher R.E., Pratt W.B. The cyclosporin A-binding immunophilin CyP-40 and the FK506-binding immunophilin hsp56 bind to a common site on hsp90 and exist in independent cytosolic heterocomplexes with the untransformed glucocorticoid receptor. J. Biol. Chem. 270:1995;20479-20484.
13. r of 63 000, 56 000, and 50 000. J. Biol. Chem. 266:1991;6708-6713.
14. Reynolds P.D., Roveda K.P., tucker J.A., Moore C.M., Velentine D.L., Scammell J.G. Glucocorticoid-resistant B-lymphoblast cell line derived from the Bolivian squirrel monkey (Saimiri boliviensis boliviensis). Lab. Animal Sci. 48:1998;364-370.
15. Sánchez E.R. Hsp56: a novel heat shock protein associated with untransformed steroid receptor complexes. J. Biol. Chem. 265:1990;22067-22070.
16. Steiner J.P., Connolly M.A., Valentine H.L., Hamilton G.S., Dawson T.M., Hester L., Snyder S.H. Neurotrophic actions of non-immunosuppressive ligands of immunophilins. Nat. Med. 3:1997;1-8.
17. Steiner J.P., Hamilton G.S., Ross D.T., Valentine H.L., Guo H., Connolly M.A., Liang S., Ramsey C., Li J., Huang W., Howorth P., Soni R., Fuller M., Sauer H., Nowotnik A.C., Suzdak P.D. Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. USA. 94:1997;2019-2024.
18. Tai P.K.K., Albers M.W., Chang H., Faber L.E., Schreiber S.L. Association of a 59-kilodalton immunophilin with the glucocorticoid receptor complex. Science. 256:1992;1315-1318.
19. Tai P.K.K., Chang H., Albers M.W., Schreiber S.L., Toft D.O., Faber L.E. P59 (FK506 binding protein 59) interaction with heat shock proteins is highly conserved and may involve proteins other than steroid receptors. Biochemistry. 32:1993;8842-8847.
20. Wang M.S., Zeleny-Pooley M., Gold B.G. Comparative dose-dependence study of FK506 and cyclosporin A on the rate of axonal regeneration in rat sciatic nerve. J. Pharmacol. Exp. Ther. 282:1997;1084-1093.